Impax Asset Management Group PLC Charles River Laboratories International, Inc. Transaction History

Impax Asset Management Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$164.52 - $238.84 $326,901 - $474,575	-1,987 Reduced 64.06%	1,115 $263,000
Q3 2023 Nov 07, 2023	SELL	$194.44 - $217.61 $27,416 - $30,683	-141 Reduced 4.35%	3,102 $607,000
Q2 2023 Aug 07, 2023	SELL	$183.71 - $210.25 $7,164 - $8,199	-39 Reduced 1.19%	3,243 $681,000
Q1 2023 May 10, 2023	BUY	$191.89 - $259.92 $216,260 - $292,929	1,127 Added 52.3%	3,282 $662,000
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $424,772 - $538,900	2,155 New	2,155 $469,000
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $1,277 - $1,810	-5 Reduced 0.53%	945 $268,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $9,135 - $11,665	-26 Reduced 2.66%	950 $358,000
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $243,677 - $292,292	976 New	976 $283,000

709

49.8M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.04B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.